News

Eli Lilly Begins Phase III Clinical Trial for Coronavirus

Eli Lilly Begins Phase III Clinical Trial for Coronavirus

The company has begun phase III clinical trials for Olumiant, which is an approved treatment for rheumatoid arthritis. The company will enroll 400 patients in the U.S., Europe, and Latin America in the trial for the potential coronavirus treatment. With depots across Latin America and Europe and headquarters in the U.S., Yourway is equipped to service global clinical trials.

Back to Index
Media

Upcoming Event

Clinical Operations in Oncology Trials East Coast 2020

July 15-16, 2020
Boston, MA, USA (Virtual)

Media

Articles

SUPPLY CHAIN SOLUTIONS – Storage and Distribution Support for Clinical Trials Worldwide

Open chat
Come chat with us!
Hello! How can I help you?